Go to content

Main menu:

Food for special medical purposes based on sodium butyrate LSC microcaps (EU patent n.2352386) with LSC® technology able to slowly release the active principle in the intestinal tract and in particular in the colon-rectum. Butyrose® is indicated for the treatment of subjects suffering from colon pathologies with altered trophism of the intestinal mucosa.
Ingredients: microencapsulated sodium butyrate (hydrogenated palm oil*, sodium butyrate, bulking agent: E 516 and E 470a, flavorings, glazing agent: E 477), vegetable capsule (coating agent: E 464, colorant E 171** ). No sugar,
yeast, gluten or lactose.
How to use: 2-3 capsules a day, with meals, if you have difficulty swallowing, you can open the capsule and take over the content of dispersing it in beverages or semi-solid food. There are no time limits to the administration.
Packing: 30 or 15 slow release
capsules of 670 mg containing 550 mg of sodium butyrate Lsc Microcaps.

*Contains certified sustainable palm oil:

*RSPO License n. 9-1708-16-100-00

**the colorant is present exclusively in the external operculum

Back to content | Back to main menu